Inactivation of traP Has No Effect on the Agr Quorum-Sensing System or Virulence of Staphylococcus aureus
- 1 September 2007
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 75 (9) , 4519-4527
- https://doi.org/10.1128/iai.00491-07
Abstract
The success of Staphylococcus aureus as a pathogen can largely be attributed to the plethora of genetic regulators encoded within its genome that temporally regulate its arsenal of virulence determinants throughout its virulence lifestyle. Arguably the most important of these is the two-component, quorum-sensing system agr. Over the last decade, the controversial presence of a second quorum-sensing system (the TRAP system) has been proposed, and it has been mooted to function as the master regulator of virulence in S. aureus by modulating agr. Mutants defective in TRAP are reported to be devoid of agr expression, lacking in hemolytic activity, essentially deficient in the secretion of virulence determinants, and avirulent in infection models. A number of research groups have questioned the validity of the TRAP findings in recent years; however, a thorough and independent analysis of its role in S. aureus physiology and pathogenesis has not been forthcoming. Therefore, we have undertaken such an analysis of the TRAP locus of S. aureus. We found that a traP mutant was equally hemolytic as the wild-type strain. Furthermore, transcriptional profiling found no alterations in the traP mutant in expression levels of agr or in expression levels of multiple agr-regulated genes (hla, sspA, and spa). Analysis of secreted and surface proteins of the traP mutant revealed no deviation in comparison to the parent. Finally, analysis conducted using a murine model of S. aureus septic arthritis revealed that, in contrast to an agr mutant, the traP mutant was just as virulent as the wild-type strain.This publication has 81 references indexed in Scilit:
- RNAIII-Inhibiting-Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm FormationAntimicrobial Agents and Chemotherapy, 2007
- Treatment of Staphylococcus aureus Biofilm Infection by the Quorum-Sensing Inhibitor RIPAntimicrobial Agents and Chemotherapy, 2007
- Investigations into σ B -Modulated Regulatory Pathways Governing Extracellular Virulence Determinant Production in Staphylococcus aureusJournal of Bacteriology, 2006
- A slipped‐mispairing mutation in AgrA of laboratory strains and clinical isolates results in delayed activation of agr and failure to translate δ‐ and α‐haemolysinsMolecular Microbiology, 2006
- RNAIII‐Inhibiting Peptide Significantly Reduces Bacterial Load and Enhances the Effect of Antibiotics in the Treatment of Central Venous Catheter–AssociatedStaphylococcus aureusInfectionsThe Journal of Infectious Diseases, 2006
- The role and regulation of the extracellular proteases of Staphylococcus aureusMicrobiology, 2004
- RNAIII inhibiting peptide (RIP) inhibits agr-regulated toxin productionPeptides, 2001
- Activation and Inhibition of the Staphylococcal AGR SystemScience, 2000
- Structure of the pheromone peptide of the Staphylococcus epidermidis agr systemFEBS Letters, 1998
- Staphylococcal Coagulase: Mode of Action and AntigenicityMicrobiology, 1952